12:00 AM
Jan 05, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

OMS201: Phase I data

In a double-blind, vehicle-controlled Phase I trial in patients undergoing endoscopic removal of urinary stones, OMS201 did not produce serious adverse events....

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >